Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-14T01:59:49.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the dosing schedule of VS-6766 alone and in combination with everolimus for patients with solid tumors and Multiple Myeloma in a Phase I trial.
    Difference
    0.1%
    Check dated 2024-06-06T16:02:22.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of what eligibility criteria entail.
    Difference
    40%
    Check dated 2024-05-22T12:51:43.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    0.6%
    Check dated 2024-05-01T17:40:38.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.